Advanced Enzyme Technologies Limited Stock

Equities

ADVENZYMES

INE837H01020

Specialty Chemicals

Market Closed - NSE India S.E. 07:40:28 2024-06-11 am EDT 5-day change 1st Jan Change
361.6 INR +0.35% Intraday chart for Advanced Enzyme Technologies Limited +4.19% -3.68%
Sales 2025 * 7.01B 83.94M Sales 2026 * 7.89B 94.4M Capitalization 40.43B 484M
Net income 2025 * 1.8B 21.5M Net income 2026 * 2.11B 25.3M EV / Sales 2025 * 5.76 x
Net cash position 2025 * - 0 Net cash position 2026 * - 0 EV / Sales 2026 * 5.13 x
P/E ratio 2025 *
22.6 x
P/E ratio 2026 *
19.1 x
Employees 338
Yield 2025 *
0.55%
Yield 2026 *
0.55%
Free-Float 42.97%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Advanced Enzyme Technologies Limited, Q4 2024 Earnings Call, May 15, 2024
Advanced Enzyme Technologies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Advanced Enzyme Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Advanced Enzyme Technologies Limited Announces Cessation of Kedar J. Desai as Independent Director CI
Advanced Enzyme Completes Acquisition of Additional 5.9% Stake in Subsidiary JC Biotech MT
Advanced Enzyme Technologies Limited acquired additional 5.89% stake in Jc Biotech Private Limited for INR 56.1 million CI
Transcript : Advanced Enzyme Technologies Limited, Q3 2024 Earnings Call, Feb 16, 2024
Advanced Enzyme Technologies to Lift Stake in JC Biotech to Nearly 96% MT
Advanced Enzyme Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Advanced Enzyme Technologies Limited agreed to acquire additional 5.89% stake in Jc Biotech Private Limited for INR 56.1 million. CI
Crisil Keeps A+ Rating on Advanced Enzyme Technologies' Bank Loans; Outlook Stable MT
Transcript : Advanced Enzyme Technologies Limited, Q2 2024 Earnings Call, Nov 10, 2023
Advanced Enzyme Technologies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Transcript : Advanced Enzyme Technologies Limited, Q1 2024 Earnings Call, Aug 16, 2023
Transcript : Advanced Enzyme Technologies Limited - Shareholder/Analyst Call
More news

Latest transcript on Advanced Enzyme Technologies Limited

1 day+0.35%
1 week+4.19%
Current month-0.34%
1 month-8.19%
3 months+0.50%
6 months-1.16%
Current year-3.68%
More quotes
1 week
352.50
Extreme 352.5
365.20
1 month
334.05
Extreme 334.05
389.75
Current year
334.05
Extreme 334.05
425.15
1 year
265.60
Extreme 265.6
425.15
3 years
225.00
Extreme 225
448.00
5 years
98.10
Extreme 98.1
503.70
10 years
98.10
Extreme 98.1
503.70
More quotes
Managers TitleAgeSince
Director of Finance/CFO 60 02-08-31
Compliance Officer - 17-02-13
Director/Board Member 51 14-12-07
Members of the board TitleAgeSince
Director/Board Member 49 19-11-01
Director/Board Member 61 22-06-30
Director/Board Member 54 16-12-13
More insiders
Date Price Change Volume
24-06-11 361.6 +0.35% 279,837
24-06-10 360.3 -0.73% 201,949
24-06-07 363 +0.60% 110,719
24-06-06 360.8 +2.35% 77,145
24-06-05 352.5 +1.59% 157,748

Delayed Quote NSE India S.E., June 11, 2024 at 07:40 am EDT

More quotes
Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
361.6 INR
Average target price
470 INR
Spread / Average Target
+30.00%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ADVENZYMES Stock